Cytelife Healthcare Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -3337.74%
- Ebitda -3337.74%
- Net Worth -102.67%
- Total Assets -90.63%
About Cytelife Healthcare Services
Cytelife Healthcare Services Private Limited (CHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 September 2015 (Nine years and four months 27 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aishah Chaudhary, Sameer Khan, and Mohammad Daud serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24301MH2015PTC268172
-
Company No.
268172
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Sep 2015
-
Date of AGM
28 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cytelife Healthcare Services?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aishah Chaudhary
|
Director | 14-Apr-2019 | Current |
|
Sameer Khan
|
Director | 07-Sep-2015 | Current |
|
Mohammad Daud
|
Director | 07-Sep-2015 | Current |
Financial Performance of Cytelife Healthcare Services.
Cytelife Healthcare Services Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3337.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 102.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytelife Healthcare Services?
In 2019, Cytelife Healthcare Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cytelife Pharmaceuticals LlpAishah Chaudhary and Mohammad Daud are mutual person
-
Sauz Consultants Private Limited
Sameer Khan is a mutual person
-
Cytelife Remedies Limited
Mohammad Daud is a mutual person
-
Rekonnect Consultants Private Limited
Mohammad Daud is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytelife Healthcare Services?
Unlock and access historical data on people associated with Cytelife Healthcare Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytelife Healthcare Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytelife Healthcare Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.